Las Vegas, NV -- (SBWIRE) -- 09/28/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: Thermo Fisher Scientific Inc.(NYSE:TMO), Biogen Idec Inc(NASDAQ:BIIB), Covidien plc (NYSE:COV), Cardium Therapeutics Inc (NYSEMKT:CXM)
Thermo Fisher Scientific Inc.(NYSE:TMO) Saw its volume 1.13 million shares changed hands when compared with its average daily volume of 1.44M shares. The stock was at $65.92. It has gone up over the last 12 months at 45.83% and marked new low $57.21. Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics.
Has TMO Found The Bottom and Ready To Move Up? Find Out Here
Biogen Idec Inc(NASDAQ:BIIB) settled at $244.82 on above-normal volume of 1.12M shares during the last trading day. The stock has its 12-month high at $248.95 and 52-week low price was $134.00. It traded in a range of $238.47 to $245.16 during the last trading day. Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally.
Has BIIB Found The Bottom And Ready To Gain Momentum? Find Out Here
Covidien plc (NYSE:COV) traded down on a volume of 1.12 million. Shares have gone down -0.02% to $60.96. Over the last twelve months, the stock has gained 5.58% and faced a worst price of $53.36. Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide.
What was the Moving Force behind COV On Bullish Run? Read This Research Report
Cardium Therapeutics Inc (NYSEMKT:CXM) managed to go up at 27.76% on above-normal volume of 1.11 million shares. The stock settled at $1.03 after floating in a range of $0.79 to $1.08. Its latest price was $1.03, reaching market capitalization of $7.57 million. Its 52-week range has been $0.58 to $4.80. Cardium Therapeutics, Inc., a medical technology company, engages in the development and commercialization of products and devices for cardiovascular and ischemic diseases, wound healing, and tissue repair.
Can Investors Bet on CXM after this News update? Just Go Here And Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)